Nuvation Bio Inc. (NUVB)
NYSE·Healthcare·Biotechnology
$4.58
+0.28%
Mkt Cap $1.75B
Next Earnings
In 5 daysMon, May 4, 2026
EPS Estimate
$0.05
2 analysts
Revenue Estimate
$66.22M
Last quarter: beat by +0.00% on EPS, +10.71% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.75B
P/E
—
Fwd P/E
—
P/S
27.77
Rev TTM
—
EPS TTM
-$0.60